EUVIMEDEUVIMED entdecken
Crossref

Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway

Junfeng Li, Zhongxiang Jiang, Jin He, Kun Yang, Jun Chen iD, Qianxi Deng, Xiaoqing Li, Fan Wu, Shuman Xu, Zheng Jiang iD

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Junfeng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neovascularization, Pathologic, Transforming Growth Factor beta, Cell Proliferation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a common digestive tract tumor with the third incidence and death in the world. There is still an urgent need for effective therapeutic targets and prognostic markers for CRC. Herein, we report a novel potential target and marker, Chordin like‐1 (CHRDL1). The function of CHRDL1 has been reported in gastric cancer, breast cancer, and oral squamous cell carcinoma. However, the biological effect of CHRDL1 in CRC remains unrevealed. Transwell and tube formation experiments were used to determine the biological function of CHRDL1. Western blot and rescue experiments were used to determine the specific mechanisms of CHRDL1. Results showed CHRDL1 is significantly downregulated in CRC cell lines and tissues. In vitro, experiments confirmed that CHRDL1 can inhibit cell growth, migration, invasion, angiogenesis and reverse epithelial‐mesenchymal transformation. In vivo, experiments proved that it can inhibit tumor growth and metastasis. Mechanistically, we newly find that CHRDL1 exerts biological functions through the transforming growth factor‐beta (TGF‐β)/vascular endothelial growth factor signaling axis in vitro and in vivo. Therefore, we concluded that CHRDL1 reduces the growth, migration, and angiogenesis of CRC cells by downregulating TGF‐β signaling. Our new findings on CHRDL1 may provide a basis for clinical antiangiogenesis therapy and the prognosis of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeovascularization, PathologicTransforming Growth Factor betaCell ProliferationSignal TransductionVascular Endothelial Growth Factor ACell MovementEpithelial-Mesenchymal TransitionHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticMice, NudeFemaleNeoplasm MetastasisXenograft Model Antitumor AssaysMice, Inbred BALB CAngiogenesis

Stichwörter der Autor:innen

antiangiogenesisgene expressionprognostic

Substanzen

Transforming Growth Factor betaVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Jun Chen, Zheng Jiang

Zitieren

APA

Li, J., Jiang, Z., He, J., Yang, K., Chen, J., Deng, Q., Li, X., Wu, F., Xu, S., & Jiang, Z. (2024). Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23711

Vancouver

Li J, Jiang Z, He J, Yang K, Chen J, Deng Q, et al. Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23711

BibTeX
@article{Li2024,
  author = {Li, Junfeng and Jiang, Zhongxiang and He, Jin and Yang, Kun and Chen, Jun and Deng, Qianxi and Li, Xiaoqing and Wu, Fan and Xu, Shuman and Jiang, Zheng},
  title = {Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23711}
}
Kostenlos starten →